Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.

Fishman, D A

Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer. [electronic resource] - Gynecologic oncology Apr 1995 - 105-8 p. digital

Publication Type: Case Reports; Journal Article

0090-8258

10.1006/gyno.1995.1105 doi


Adult
Biomarkers--analysis
Chemotherapy, Adjuvant
Cisplatin--therapeutic use
Cyclophosphamide--therapeutic use
Cystadenocarcinoma, Serous--complications
Female
HIV Infections--complications
HIV-1
Humans
Ovarian Neoplasms--complications